2,4,5-Trifluorobenzonitrile

We are 2,4,5-Trifluorobenzonitrile CAS:98349-22-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,4,5-Trifluorobenzonitrile
CAS.NO:98349-22-5
Synonyms:2,4,5-Trifluorobenzonitrile
2,4,5-trifluoro-benzonitrile
Benzonitrile,2,4,5-trifluoro
Molecular Formula:C7H2F3N
Molecular Weight:157.09300
 
Physical and Chemical Properties:
Density:1.373
Boiling point:168-170ºC
Flash point:182°F
Index of Refraction:1.4736
 
Specification:
Appearance:Colorless liquid
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2,4,5-Trifluorobenzonitrile


Related News: First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory. 2-bromo-3-fluoropiridina CAS:40273-45-8 We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.[dimetilamino- (2-oxopiridin-1-il) oximetilideno] -dimetilazanio, hexafluorofosfato CAS:364047-51-8 Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.2-Allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.

Related Products
Product Name
Dodecyl 2-methylacrylate View Details
4-((2-Furylmethyl)thio)-4-methylpentan-2-one View Details
Hecogenin View Details
(S)-4-(4-hydroxy-benzyl)-oxazolidine-2,5-dione manufacturer 2-Amino-5-diethylaminopentane manufacturer L-CYSTEINE manufacturer trimethyl benzene-1,3,5-tricarboxylate manufacturer 2-BROMODIBENZOTHIOPHENE manufacturer